Rosemary Crane resigned from Tarsus Pharmaceuticals' Board effective January 17, 2025, but will continue as a consultant; Wendy Yarno was appointed Chairperson of the Commercial Committee and Andrew Goldberg joined the Audit Committee on the same dat...